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Abstract: This study considers gene location within bacteria as a function of genetic element mobility. Our emphasis is on 
prophage encoding of bacterial virulence factors (VFs). At least four mechanisms potentially contribute to phage encoding 
of bacterial VFs: (i) Enhanced gene mobility could result in greater VF gene representation within bacterial populations. 
We question, though, why certain genes but not others might beneﬁ  t from this mobility. (ii) Epistatic interactions—between 
VF genes and phage genes that enhance VF utility to bacteria—could maintain phage genes via selection acting on indi-
vidual, VF-expressing bacteria. However, is this mechanism sufﬁ  cient to maintain the rest of phage genomes or, without 
gene co-regulation, even genetic linkage between phage and VF genes? (iii) Phage could amplify VFs during disease pro-
gression by carrying them to otherwise commensal bacteria colocated within the same environment. However, lytic phage 
kill bacteria, thus requiring assumptions of inclusive ﬁ  tness within bacterial populations to explain retention of phage-
mediated VF ampliﬁ  cation for the sake of bacterial utility. Finally, (iv) phage-encoded VFs could enhance phage Darwinian 
ﬁ  tness, particularly by acting as ecosystem-modifying agents. That is, VF-supplied nutrients could enhance phage growth 
by increasing the density or by improving the physiology of phage-susceptible bacteria. Alternatively, VF-mediated break 
down of diffusion-inhibiting spatial structure found within the multicellular bodies of host organisms could augment phage 
dissemination to new bacteria or to environments. Such phage-ﬁ  tness enhancing mechanisms could apply particularly given 
VF expression within microbiologically heterogeneous environments, ie, ones where phage have some reasonable potential 
to acquire phage-susceptible bacteria.
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Viruses are either the simplest of living things or are among the more complex of non-living things. At 
the very least, viral gene pools can form a continuum with those of their hosts, with gene exchange and 
recombination occurring between viral and host DNA. This gene exchange can be so pervasive that the 
viruses of bacteria—known as phages or bacteriophages—have been suggested as substantial or even 
the most signiﬁ  cant drivers of bacterial evolution (Krisch 2003). So-called temperate phage appear to 
play particularly important roles in bacterial evolution since, as prophage, they are able to establish 
long-term genetic symbioses with their hosts, typically by the phage genome directly (though revers-
ibly) integrating into the host chromosome. Together these prophage-bacterial combinations are described 
as lysogenic bacteria or, simply, as lysogens.
Numerous bacterial virulence factors (VFs)—agents known to contribute to the development of 
infectious disease in eukaryotes such as ourselves—have been shown to be encoded by prophage 
(Brüssow et al 2004). Human diseases directly caused by prophage-encoded VFs include (but are not 
limited to) botulism, diphtheria, cholera, and those associated with Shiga toxigenic Escherichia coli 
such as E. coli O157 (Boyd et al 2001; Boyd and Brüssow 2002; Brüssow et al 2004; Boyd 2005). 
Indeed, the deﬁ  ning exotoxin for each of the listed diseases—respectively botulism toxin, diphtheria 
toxin, cholera toxin, and Shiga toxin—is expressed from a phage-encoded gene. The emergence and 
progression of many bacterially mediated infectious diseases consequently are affected by temperate-
phage movement between bacteria (Breitbart et al 2005) as well as by prophage-mediated control of 
VF production (Wagner and Waldor 2002).
Though phage encoding of virulence-factor genes is important to an understanding of many bacterially 
mediated infectious diseases, here we will consider a more fundamental issue: Why do phage, particu-
larly prophage, even encode VFs? In principle there exist at least four entities that could selectively 
beneﬁ  t from the resulting association: the VF gene, the bacterium host, bacterial populations, and the 
encoding phage/prophage. Furthermore, a given VF-associated phenotype could simultaneously ben-
eﬁ  t any or all of these four entities. We list in Table 1 the various mechanisms considered here which 98
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could contribute to the maintenance of prophage-VF 
associations. Of those ten mechanisms, we note 
that only one conceivably benefits individual 
VF-expressing bacteria (mechanism 6: Epistasis 
linking VF and phage genes). By contrast, ﬁ  ve of 
our proposed mechanisms instead beneﬁ  t particu-
larly the VF-expressing gene (mechanisms 1-5) 
while two or three (depending on the system) 
beneﬁ  t the bacterial population (ie, rather than 
individual, VF-expressing bacteria; mechanisms 
7 and 8, plus 6 for some systems). Alternatively, 
beneﬁ  ts may be accrued by VF-gene harboring 
phage (mechanisms 9 and 10).
The order in which we discuss these mechanisms 
reflects our bias in considering especially the 
virions of lytic phage to be distinct organisms. That 
is, as bacterial predators, parasites, or horizontally 
transmitted entities, the virions of lytic phage, even 
of temperate phage, exist at least semi-autonomously 
from their bacterial hosts. Such a perspective— 
which we believe may be key to understanding 
why temperate phage appear to commonly encode 
bacterial VFs—contrasts a viewing of phage 
(especially prophage) instead as somewhat integral 
components of various bacterial pathogens. In 
terms of levels of selection, we therefore order our 
discussion of the mechanisms contributing to 
phage maintenance of bacterial VF genes by going 
from gene to prophage to individual bacterium to 
bacterial population, but only subsequently, and 
separately, do we discuss selection acting upon 
phage virions. Thus, we consider a three-organism/
four-component system—phage, bacterial host, 
eukaryotic host, and VF—where VFs are active 
against eukaryotic hosts, are expressed within and 
by bacteria, and are horizontally transmitted 
between bacteria by the phage virions produced 
by induced prophage.
Where appropriate we extend our emphasis to 
include non-phage mobile genetic elements 
(MGEs; Davis and Waldor 2002), particularly 
plasmids, since a number of authors consider 
Table 1: Mechanisms selecting gene-prophage associations plus primarily beneﬁ  ting entities.
Selecting mechanism Beneﬁ  ting entities
gene bacterium bacter. pop. phage
1 Gene survival via greater mobility 3
a 8
b 8
c 8
2 Genetic hitchhiking on more-ﬁ  t bacterial lineages 3 88 8
3 Gene escape from immune surveillance 3 88 8
4 Gene extrabacterial survival 3 88
c —
d
5 Faster gene evolution 3 —
e —
e —
6 Epistasis linking VF and phage genes — 3
f 3
g —
7 Dissemination of an effective toxin dose —
h 8
i 3
g —
8 Lysogen allelopathy — 8
i 3
j —
9 Direct enhancement of phage ﬁ  tness — 88 3
10 Indirect enhancement of phage ﬁ  tness — 88 3
k
a In constructing this table we assume that if at any time a gene/allele contributes to the ﬁ  tness of a harboring organism, then that gene is 
under positive natural selection. We indicate (with a tick) that the gene is a primarily beneﬁ  ting entity only when gene beneﬁ  ts cannot be 
explained solely on the basis of enhancing the ﬁ  tness of a or the harboring organism. 
b We employ a cross to indicate a relative lack of 
beneﬁ  ts to the indicated entity. We do not distinguish in this table between selection acting on prophage versus uninduced bacterial lysogens. 
c An alternative view is that gene mobility and extra-bacterial survival (ie, as within phage virions) can be beneﬁ  cial to bacterial populations 
or communities by retaining a reserve of functions among bacteria, but we would view hypotheses based solely on such a perspective to 
be inherently group selectionist, especially given arguments that bacteria do not retain gene exchange mechanisms for the sake of gene 
exchange (Redﬁ  eld 1993; Redﬁ  eld 2001) and therefore likely do not contribute greatly to a retention of gene-prophage associations. 
d Phage 
ﬁ  tness-enhancing effects we consider solely in rows 9 and 10. We indicate absence of any comment on utility with the symbol —. 
e Our 
arguments assume that faster gene evolution requires gene mobility (see 
c, above). 
f Such linkage can contribute to VF survival independent 
of bacterial ﬁ  tness (as indicated in row 4), but in other cases may be considered to contribute to VF expression and thereby to bacterial 
ﬁ  tness. 
g Because VF deployment in some instances requires expressing-bacteria death, we also invoke “bacterial population” as a poten-
tial beneﬁ  ciary of this deployment. 
h Dissemination should contribute to gene mobility, but gene mobility we cover in rows 1-3. 
i Since these 
mechanisms involve phage-induced lysis of phage-producing bacteria, the beneﬁ  ting entity would be the bacterial population rather than 
the producing bacterium. 
j Lysogen allelopathy we speculate can augment the ﬁ  tness advantages associated with gene-prophage associa-
tions rather than representing a mechanism sufﬁ  cient to explain such associations. 
k This enhancement could occur in terms of phage 
replication or dissemination, and mechanisms which may enhance phage dissemination within or between environments could presumably 
also enhance bacterial dissemination within or between environments.99
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concepts relevant to phage-VF gene coevolution 
when considering the evolution of gene-MGE 
associations. Our fundamental aim, however, is the 
exploration of bacterial pathogenesis from the 
perspective of phage ecology. See Brüssow et al 
(2004) for review of the phage impact on the evo-
lution of bacterial pathogens. See Chibani-
Chennouﬁ   et al (2004) and Breitbart et al (2005) 
for reviews of phage ecology as it applies to bacte-
rial pathology, and Waldor et al (2005) for a general 
review of the phage impact on bacterial pathology. 
See Chibani-Chennouﬁ   et al (2004) and Abedon 
(2006) for overviews of phage ecology in 
general.
Enhancement of Gene Fitness
Selection acting on individual bacteria does not 
necessarily favor a continued gene-prophage or, 
more generally, a gene-MGE association. For 
instance, if a gene confers some beneﬁ  t to a harbor-
ing bacterium, but an encoding prophage does not 
otherwise confer any advantage to the same bac-
terium, then over time we would expect evolution 
to favor a deletion of the prophage sequences 
accompanying a given gene (Ziebuhr et al 1999; 
Lawrence et al 2001; Desiere et al 2001; Brüssow 
et al 2004; Brüssow 2006) (see Bergstrom et al 
2000 and Levin and Bergstrom 2000 for similar 
arguments vis-à-vis plasmids). Such deletions 
result in gene immobilization (a.k.a., “anchoring” 
or “ﬁ  xation”) within a bacterial genome (Bergstrom 
et al 2000; Levin and Bergstrom 2000; Davis and 
Waldor 2002). Alternatively, selection for gene loss 
could act on prophage, purging or replacing phage 
genes that do not contribute to phage ﬁ  tness. Such 
purging may be complicated, however, by size-
dependent efﬁ  ciencies of DNA packaging into 
phage capsids (Hendrix et al 2000; Hendrix and 
Casjens 2006). Contrasting these consequences of 
instability in the relationships between genes, 
prophage (or other MGEs), and bacteria, in this 
section we consider mechanisms based on advan-
tages conferred to genes by mobility such that 
gene-phage or gene-MGE associations may be 
selectively maintained.
1. Gene survival via greater mobility
A gene found in association with a phage or other 
MGE could be maintained within a bacterial 
population simply if, as a consequence of that 
association, the gene is dispersed to new bacteria 
faster than the gene is deleted from individual 
bacteria (Eberhard 1990; Bergstrom et al 2000; 
Wagner and Waldor 2002). Enhanced mobility due 
to generalized transduction, in which a bacterial 
rather than phage gene is disseminated to new 
bacteria, is also thought to be capable of increasing 
the likelihood of gene maintenance within bacterial 
populations (Miller 2001). Since selection acting 
at the level of individual bacteria can favor the 
deletion of rarely utilized (Roth et al 1996) or 
otherwise costly genes, phage-mediated mobility 
could be particularly advantageous for genes that 
only rarely enhance bacterial ﬁ  tness (Eberhard 
1990; Levin and Tauxe 1996; Lawrence 1997; 
Levin and Bergstrom 2000), such as those coding 
for antibiotic resistance or for xenobiotic com-
pound degradation (Eberhard 1990; de la Cruz and 
Davies 2000). Indeed, to provide an immediate 
ﬁ  tness advantage to a recipient bacterium a gene 
would need to be better than the equivalent gene 
already found in that bacterium, a scenario that is 
unlikely given a lack of a priori coevolution 
between gene and bacterium, or alternatively (and 
more likely) provide or augment a novel or exist-
ing function (Lawrence and Hendrickson 2003). 
Lawrence (1997) argues similarly that the evolu-
tion of non-essential bacterial operons by a gradual 
building up of weakly selected, horizontally trans-
ferred genes is more consistent with novel rather 
than essential functions.
From the bacterial perspective, rarely utilized 
genes represent “a scattered reserve of ‘optional’ 
functions that enable populations or species to 
respond to new environmental contingencies” 
(Eberhard 1990) (see also Reanney 1976; Boyd and 
Brüssow 2002; Brüssow 2006). This occasional 
utility to bacteria—equivalent to phage “paying for 
dinner” (Levin and Bergstrom 2000), “paying their 
rent” (Adhya et al 2005) or, simply, “rent” (Hendrix 
2005), or appeasing a bacterium with a “peace 
offer” (Desiere et al 2001) (also Hendrix et al 2000; 
Boyd and Brüssow 2002; Brüssow 2006; Hendrix 
and Casjens 2006)—would then help deﬁ  ne the 
equilibrium frequency within a population at which 
a gene survives. In other words, phage may offset 
the metabolic and other costs associated with pro-
phage harboring within a bacterium by supplying 
that bacterium with functions that the bacterium 
would otherwise not possess, though it is question-
able whether these additional functions would be 
useful under all environmental circumstances. 100
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Lysogens nevertheless should display less of a 
disadvantage (or perhaps even display an advan-
tage; Edlin et al 1975; 1977; Lin et al 1977) when 
prophage carry these peace offers, thereby selecting 
for peace offer retention within phage genomes. As 
Hendrix (2005) describes the situation, prophage 
deletion is more difﬁ  cult, from a bacterial ﬁ  tness 
perspective, given the embedding within a prophage 
of lysogen-fitness enchancing genes. Phage-
associated peace offers can range from phage-
encoded immunity functions against subsequent 
phage infection to factors that enhance bacterial 
virulence, ie, VFs.
If mobility selects for gene-MGE associations, 
then should we expect preferential MGE associa-
tion with certain types of genes? In one approach 
to answering that question, Levin and Bergstrom 
(2000) argue that the need for peace offers (or being 
“nice” to their hosts as they describe the concept) 
likely is greater the less efﬁ  cient (or less effective) 
the method of MGE horizontal transfer. Prophage— 
with robust mechanisms of release from bacterial 
hosts (eg, via phage-induced bacterial lysis; Young 
2005) along with effective mechanisms of 
acquisition of new bacteria (ie, via virion 
adsorption)—possess a highly efﬁ  cient means 
whereby genes may be horizontally transferred 
between bacteria. We therefore might predict a 
reduced bacterial utility associated with phage-
encoded VFs compared to, for example, plasmid-
encoded VFs. Stated more strongly, it is conceivable 
that phage-encoded VFs could even be detrimental 
to the ﬁ  tness of harboring bacterial lysogens espe-
cially if phage-virion mediated horizontal transmis-
sion can make up for VF ﬁ  tness costs associated 
with prophage-mediated vertical transmission.
2. Genetic hitchhiking on more-ﬁ  t 
bacterial lineages
The above-posited mechanism(s) suggest that some 
combination of gene mobility and infrequent selec-
tion could be sufﬁ  cient to maintain gene-prophage 
(or gene-MGE) associations. Note that we made 
no assumption of ﬁ  tness differences between bac-
teria receiving MGE-associated genes, except 
following prophage (or MGE) acquisition. By 
contrast, there exists a second gene-centered expla-
nation for maintenance of gene-MGE associations—
one that presumes differences in bacterial ﬁ  tness 
prior to, rather than following, prophage or MGE 
acquisition (Eberhard 1990; Turner et al 1998; 
Bergstrom et al 2000; Levin and Bergstrom 2000). 
Here the idea is that some bacterial lineages are 
inherently more ﬁ  t within a given environment. 
Those lineages that are less ﬁ  t may be driven to 
extinction, or, at least, will be at a competitive 
disadvantage to more-ﬁ  t lineages. It stands to rea-
son that genes that hitchhike on more-ﬁ  t bacterial 
lineages can display a higher ﬁ  tness than genes 
associated with less-fit lineages. Since MGE-
associated genes are more mobile than other bacte-
rial genes, the likelihood of a gene becoming 
associated with higher-ﬁ  tness bacterial lineages 
should be greater than that of bacterial genes not 
associated with MGEs. More to the point, the 
likelihood of a gene being associated with at least 
one bacterial lineage that is not subsequently driven 
to extinction, eg, as via periodic selection (Koch 
1974; Lenski 1984; Tiedje et al 1989), should be 
greater given greater gene mobility.
Still, from the bacterium’s perspective, once 
genes have been acquired there should be little 
incentive to retain, via this hitchhiking mechanism, 
a gene-prophage (more generally, gene-MGE) 
association (Davis and Waldor 2002): Not only are 
prophage potentially harmful to harboring 
bacteria—eg, due to metabolic demands associated 
with replicating prophage DNA as well as lysis-
mediated virion release following prophage induc-
tion (Lawrence et al 2001; Brüssow 2006)—but 
so also should be the sharing, via prophage-
mediated transfer, of useful genes with competing 
bacterial lineages. Thus, even though it is a reason-
able argument that bacterial pathogens may be 
pieced together by their sequential acquisition of 
prophage and other MGE-encoded VFs (Brüssow 
2006), such an argument does not explain why the 
sequence of the carrying prophage should be 
retained, over long time spans, within a given 
bacterial lineage.
3. Gene escape from immune 
surveillance
If greater bacterial invasiveness results in an 
increase in bacterial susceptibility to a host’s 
immune response, and acquisition of an MGE-
encoded VF gives rise to greater bacterial invasive-
ness (eg, Boyd 2005), then VF acquisition could 
ultimately result in a decline in the ﬁ  tness associ-
ated with a speciﬁ  c bacterial serotype within an 
infected animal. Greater invasiveness, as a 
consequence of opening new niches for bacterial 101
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propagation, nevertheless could be equated with 
greater bacterial ﬁ  tness over shorter time frames 
(eg, Levin and Bull 1994; Frank 1996). An MGE-
associated VF gene could thereby enhance bacte-
rial invasiveness/short-term ﬁ  tness as a peace offer. 
Ultimately, however, if greater invasiveness gives 
rise to greater antibacterial speciﬁ  c immunity, then 
the same VF could contribute to an animal-host 
speciﬁ  c decline in the ﬁ  tness of a VF-harboring 
bacterial lineage.
If the bacterium’s antigenicity is bacterium 
encoded rather than bestowed by a MGE-encoded 
gene, then MGE association would allow the VF 
gene to relatively easily acquire alternative bacte-
rial hosts that are not currently recognized by an 
animal’s immune response. To our knowledge this 
speciﬁ  c scenario has not been observed within a 
single animal over the course of bacterial infection. 
Over a community of animal hosts, however, such 
a scenario would be equivalent to VF horizontal 
transfer to bacteria displaying a wide range of 
antigenic variation (Breitbart et al 2005) and would 
constitute a variation on the hitchhiking scenario 
described immediately above. As a consequence, 
an animal’s immunity to one bacterial serotype 
would not necessarily preclude subsequent VF 
utility within the same animal. Of course, this 
scenario of association with antigenically distinct 
bacterial hosts should result in advantages to any 
genes that are not speciﬁ  cally involved in modify-
ing bacterial antigenicity. Such strategies, however, 
may be especially relevant to genes, such as VF 
genes, that, by effecting bacterial invasiveness, are 
especially proﬁ  cient at provoking anti-bacterial 
immune responses.
4. Gene extrabacterial survival
Wagner and Waldor (2002) suggest that “virulence 
genes encoded by phages may withstand environ-
mental exposure better than those encoded by 
bacteria,” a hypothesis that implies selection for 
linkage between VF genes and the extracellular 
durability of phage virions as mediated by the 
phage morphogenesis genes (see also Muniesa et al 
1999; Miao and Miller 1999; Breitbart et al 2005). 
This latter possibility, however, begs the question 
of whether or to what extent biases exist whereby 
some genes tend to beneﬁ  t from this extracellular 
durability (or any other positive aspect of phage 
encoding) while others are “content” to remain 
unassociated with phage genomes. One possibility 
is that it is those genes that are less-often employed 
by bacteria (ie, as discussed above) that are less 
readily retained within the bacterial genomes by 
natural selection. To avoid extinction, such less-
employed genes presumably can more readily 
beneﬁ  t from, and indeed may require, some com-
bination of MGE-mediated population expansion 
and virion-mediated longer-term survival. These 
explanations, however, return us to the concept of 
peace offers and the question of whether or to what 
extent intermittent or non-essential gene utility to 
bacteria can select for ongoing VF association with 
prophage.
5. Faster gene evolution
Phage-mediated mobility can result in faster gene 
evolution through increased rates of mutation, 
recombination, or adaptation (Villarreal 2001). 
Implicit to an advantage associated with more-
rapid gene evolution are assumptions that genetic 
variation can increase a gene’s usefulness such as 
could occur given signiﬁ  cant environmental het-
erogeneity, eg, genetic variation as a means of 
immune-system evasion. Indeed, in some instances 
lysogenic conversion has been shown to result in 
modiﬁ  cation of a bacterium’s antigenicity (Boyd 
and Brüssow 2002; Brüssow et al 2004). Note that 
positing ﬁ  tness advantages given greater gene 
variation is not a claim that phage retain certain 
genetic sequences — such as could come into being 
as a consequence of random mutation — because 
of an anticipation of future utility. Instead, the 
argument is that the utility of a gene may be more 
readily enhanced given a more-rapid exploration 
of gene sequence space. Note that enhanced explo-
ration of sequence space mostly occurs post gene 
transmission to a new bacterial lineage (with 
recombination as a variation-generating mecha-
nism possibly an exception), and therefore does 
not beneﬁ  t the previously harboring bacterial lin-
eage so much as the recipient.
The first of these enhanced gene-evolution 
hypotheses is presented by Bishai and Murphy 
(1988) (see also Eberhard 1990). They suggest that 
MGEs, such as induced prophage, go through more 
rounds of replication than their host bacteria and 
therefore are more susceptible to mutation than 
chromosome-based genes. Alternatively, given 
their smaller genome size and proportionally lower 
DNA poly-merase precision (Drake 1991), the 
per-polymerization, per-nucleotide mutation rate 102
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of phage genes ought to be greater, given virion 
production, than the mutation rate associated with 
equivalent bacterial genes. One can also posit a 
greater potential for changing a gene’s dosage 
given association with MGEs, whether within 
multicopy plasmids, tandemly ampliﬁ  ed transpo-
sons, or multiple prophage (Eberhard 1990; 
McDonough and But-terton 1999). Given multiple 
copies it may also be possible to attain a pseudo-
gene status in which evolving genes are less 
bound by requirements for ongoing functionality. 
Lawrence (2001), however, argues that we should 
expect natural selection to counter pseudogene 
accumulation by favoring bacterial lineages that 
have deleted non-essential and, especially, bacteria-
detrimental genetic sequences.
Genes associated with MGEs may also experi-
ence more recombination events with related genes 
than do chromosome-bound genes (Eberhard 
1990). For example, many phage genomes are 
mosaic in structure. Mosaicism implies that these 
genomes have been pieced together, over evolu-
tionary time, via recombination events (Hendrix 
et al 1999; Canchaya et al 2003; Hendrix 2005) 
such as between a prophage and a superinfecting 
virus (Lawrence et al 2002) or—given polylysogeny 
(multiply lysogenized bacteria)—within “phage 
factories” (Ohnishi et al 2001). In addition to 
modifying individual structural genes, recombina-
tion can change the immediate genetic context of 
phage-associated genes (Mirold et al 2001; Krylov 
2003). A great deal of genetic variation can be 
found, for example, among prophage displaying 
otherwise similar exotoxins (Mirold et al 2001; 
Recktenwald and Schmidt 2002), and a prophage-
encoded gene presumably can have its expression 
modified by re-combinant changes in phage 
sequence external to the structural gene (LeJeune 
et al 2004). Variation in bacterium or environmen-
tal backgrounds may also occur as phage move 
from host to host (eg, as is probably observed for 
plasmid-born genes; Eberhard 1990) (see also 
Desiere et al 2001). Given MGE carriage it there-
fore seems reasonable that there exists greater 
potential for heterogeneity in the context of gene 
expression and evolution.
Enhancement of Bacterial Fitness
While mobility by itself may confer a selective 
advantage on a gene, such enhancement of a 
gene’s ﬁ  tness does not necessarily select for gene 
retention within a phage genome. Either a pro-
phage-carried gene is useful to a prophage-infected 
bacterium, with the prophage at least potentially 
expendable, or the carried gene is not often useful 
to the phage or the bacterium, thereby rendering 
the gene expendable. Consistent with the Selﬁ  sh 
Operon Model of Lawrence (1997; 2000), we 
therefore speculate that ongoing prophage reten-
tion of speciﬁ  c VF genes is more common if there 
is enhancement of phage ﬁ  tness (that is, rather 
than or in addition to enhancement of bacterial 
ﬁ  tness; Lawrence and Hendrickson 2003), or if a 
gene’s utility to its harboring bacterium is enhanced 
given prophage association. All subsequently 
considered scenarios invoke one or both of these 
criteria.
There are at least three mechanisms that could, 
by enhancing bacterial propagation, contribute to 
maintenance of an association between VF genes 
and prophage: (i) expression of phage genes lead-
ing to an increase VF utility to bacteria, (ii) virion 
packaging of VF genes to promote community-
wide mechanisms of bacterial pathogenesis (ie, by 
disseminating an effective toxin dose), and (iii) 
phage release associated with VF expression that 
results in a numerical reduction in bacteria capable 
of directly competing with the unlysed kin of 
induced lysogens (ie, by lysogen “allelopathy”). 
These are mechanisms 6, 7, and 8 as presented in 
Table 1. In the two latter cases the resulting gene 
mobility may be considered, from the bacterium’s 
perspective, as an unintended consequence of 
utilization of phage to achieve otherwise unrelated 
ends: Either toxin genes are broadcast to normal-
ﬂ  ora bacteria using replication-competent phage 
(ie, in the dissemination of an effective toxin dose) 
or replication-competent phage are employed as 
bacteriocin equivalents (ie, as in lysogen allelopa-
thy). Consequently, these latter mechanisms may 
be effectively viewed more from the perspective 
of bacterial populations or communities rather than 
solely from the perspective of the ﬁ  tness associated 
either with individual genes or individual bacteria 
(ie, as addressed in mechanisms 1 through 5, 
Table 1).
6. Epistasis linking VF and phage genes
If the selective beneﬁ  t associated with a gene is 
either enhanced or is fully dependent on the 103
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presence of additional MGE-associated genes, then 
selection may favor continued association 
(including via genetic linkage) of gene with MGE 
(Lawrence 1997). Diphtheria toxin production by 
Corynebacterium diphtheriae, for example, can be 
enhanced by the induction of the encoding pro-
phage (Wagner and Waldor 2006). Reliance on 
additional phage genes for VF expression is seen 
with the Shiga toxin genes of Escherichia coli, 
which depend upon induced bacterial lysis for toxin 
release into the extracellular environment (Plunkett 
et al 1999; Wagner et al 2002; Davis and Waldor 
2002). Lending credence to this idea of genetic 
linkage, Shiga toxin genes are co-regulated and 
approximately co-located with lambdoid lysis 
genes (Neely and Friedman 1998). Furthermore, 
in Shigella dysenteriae strain 1— which otherwise 
has completely lost phage-associated sequence—
phage lysis genes are not only present but are 
genetically linked to the Shiga toxin genes, with 
all located within a single ~5000 bp region of the 
bacterial chromosome (McDonough and Butterton 
1999; Davis and Waldor 2002). Also consistent 
with an epistatic association between phage and 
VF genes, Wagner and Waldor (2002) suggest that 
“in situ prophage induction could help to explain 
when and where certain virulence factors are pro-
duced during the course of bacterial infection.” 
Note, however, that in circumstances where pro-
phage induction is required for enhancement of VF 
utility, then the expressing bacterium—if killed by 
prophage-induced bacterial lysis—would presum-
ably not receive a direct ﬁ  tness beneﬁ  t.
7. Dissemination of an effective toxin 
dose
In this section we consider how advantages associ-
ated with VF mobility might stem from dissemi-
nated expression of a VF gene. An assumption is 
made that the advantages associated with the 
expression of certain VFs (eg, exotoxins) may be 
shared among bacteria and furthermore that these 
bacteria may beneﬁ  t from the collective production 
of a greater VF dose. To achieve this greater VF 
production it may be possible to disseminate the 
VF genes—via MGEs such as phages—throughout 
communities of normal-ﬂ  ora bacteria. This effect 
may be described as the dissemination of an effec-
tive VF (or toxin) dose (Bishai and Murphy 1988; 
Plunkett et al 1999; Gamage et al 2003). From 
Bishai and Murphy (1988):
    Phage conversion is a highly efﬁ  cient means 
of rapidly disseminating the toxin gene within 
a nonimmune host. In the case of C. diphteriae 
the bacteria double every hour in vitro, but in 
that same hour a lytic corynephage can produce 
30-60 converting phages. Nontoxigenic C. 
diphtheriae, S. pyogenes, S. aureus, and E. coli 
are all frequent if not constant members of the 
normal human ﬂ  ora. For these autochthonous 
organisms, in situ phage conversion represents 
a means of rapid spread of the toxin gene once 
a susceptible host has been infected with just 
a few toxinogenic organisms.
If phage-associated VF genes are to be 
disseminated, then prophage induction and virion 
adsorption and infection must occur in situ. Such 
interactions between phage and various bacterial 
pathogens can indeed occur over the course of at 
least experimental infection of animal hosts 
(reviewed in Table 3 of Breitbart et al 2005).
Smith (2001) provides a conceptual variation on 
dissemination of an effective toxin dose that is based 
on two assumptions: (i) That VF production may be 
costly to expressing bacteria and (ii) that factors 
released can beneﬁ  t more bacteria than just the 
immediate producers. Given gene mobility, Smith 
argues that costs of VF expression may be spread 
more equitably around a community of similar bac-
teria. Gene-MGE association, by this logic, would 
represent a means of forcing otherwise “freeloading” 
bacteria—bacteria beneﬁ  ting from VF expression 
but that are not burdened by its expression—to do 
their fair share of the gene-expression work. Note 
that coordination between gene mobilization (such 
as following lysogen induction), gene expression, 
and gene utility could allow this forcing to occur over 
the course of active disease progression. Of interest, 
however, note that the scenario that Smith presents 
could also be interpreted from the perspective of 
selection for mobility acting on genes (mechanism 1) 
rather than selection acting on bacteria, with the 
products of selectively mobile genes exhibiting a 
shared utility within bacterial populations rather than 
a rare utility as highlighted previously.
We ﬁ  nd phage dissemination of an effective 
gene dose to be a compelling explanation for 
gene-MGE association. This is true particularly 
from the perspective of disease progression. Nev-
ertheless, we have two concerns with the formu-
lation of this explanation. The ﬁ  rst concern is that 104
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if one assumes that the bacterium is the unit of 
selection, then dissemination of an effective toxin 
dose can demand an assumption of inclusive 
ﬁ  tness—the idea that the ﬁ  tness of alleles can be 
a function of the combined ﬁ  tness of related 
individuals rather than simply of the Darwinian 
fitness of individual organisms carrying and 
expressing the allele (Hamilton 1964a, 1964b) 
(see also Bossi et al 2003; Livny and Friedman 
2004). Calls for inclusive ﬁ  tness are plausible 
given maintenance of close associations among 
clonally related bacteria (Levin 1987) and occur 
by necessity if the bacteria providing the VF do 
not survive VF dissemination. Lack of survival 
of producing bacteria appears to be the case for 
Shiga toxi-genic E. coli (as discussed above) and 
also is potentially the case for two prophage-
encoded Streptococcus mitis platelet-binding 
factors (Bensing et al 2001).
The second concern involves assumptions as 
to the efﬁ  ciency of phage conversion. This con-
version can require lysogeny (as in “lysogenic” 
conversion) or, more generally, can involve either 
lysogeny, chronic phage infection, or, alterna-
tively, the lytic infection of some though not all 
bacteria in a population—all of which may be 
described as phage conversions (Barksdale and 
Ardon 1974). For lysogenic conversion to take 
place, a phage infection must be reduced to lysog-
eny. However, if reduction to lysogeny is very 
likely then “amplifying the number of virulence 
gene-encoding organisms in the body during 
infection” (Wagner and Waldor 2002) would be 
muted since it is lytic growth, not latent-period 
extensions such as lysogeny (Abedon 1989; 
Abedon et al 2001; 2003), that underlie the rapid 
phage population expansion that should fuel 
effective-dose dissemination. Thus, there exists 
an inherent conﬂ  ict between effective-dose dis-
semination and reduction to lysogeny, but typi-
cally it is lysogens (including induced lysogens), 
rather than purely lytic phage infections, that are 
emphasized when studying the production of 
phage-linked VFs.
There is no reason to believe that either of these 
concerns is in any way fatal to hypotheses on the 
dissemination of an effective toxin dose. They do 
point, however, to the importance—for the sake of 
understanding disease progression—of the in situ 
characterization of (i) probabilities of lytic-
lysogenic decisions, (ii) the potential of purely lytic 
infections to produce phage-encoded toxins, (iii) 
phage host range, and (iv) whether inclusive-ﬁ  tness 
beneﬁ  ts really are sufﬁ  cient to select for VF reten-
tion among bacterial pathogens. Some of these 
considerations have been addressed for V. cholerae, 
which potentially employs phage-mediated toxin 
dose dissemination in the course of infection (Lazar 
and Waldor 1998; Faruque et al 2001). Further-
more, expression and release of cholera toxin 
appears to bypass absolute requirements for inclu-
sive fitness for continuation of the phage-VF 
association since cholera toxin (as well as phage 
release) does not require infected-bacterium lysis. 
Gamage et al (2003; 2004) similarly explore some 
of these issues, both in vitro and in situ, in terms 
of Stx production upon presumptively lytic infec-
tion of E. coli.
8. Lysogen allelopathy
Inefﬁ  cient reduction to lysogeny can provide an 
alternative explanation of why toxin genes may 
associate with prophage, via a phenomenon that 
Stewart and Levin (1984) call lysogen allelopathic 
effects. The term allelopathy is borrowed from the 
ability of some plants to chemically block the 
growth of plant competitors. By lysogen allelopathy, 
Stewart and Levin imply that phage released from 
induced bacterial lysogens may block the growth 
of competing bacteria by infecting and subse-
quently killing those bacteria. By releasing phage 
just as toxins are released from induced lysogens, 
the remaining (uninduced) lysogens may accrue 
any beneﬁ  t associated with toxin production just 
as potentially competing bacteria (eg, competing 
for nutrients or for space) are infected and then 
lysed by these phage.
Bacteriocins, including some defective 
prophage, could effect a similar competition-
minimizing result (Eberhard 1990), but, unlike 
intact phage, are not equipped to disseminate an 
effective toxin dose. Note that allelopathic effects 
additionally can serve as a defensive measure since 
phage-attacked bacterial competitors should posses 
a reduced potential to display allelopathic effects 
in return. Extension and some experimental veri-
ﬁ  cation of these ideas on lysogen allelopathy can 
be found as applied to Salmonella (Bossi et al 
2003) or Streptomyces (Smith 2006) ecology and 
as a novel approach (Platt et al 2003) towards the 
phage-therapeutic treatment of bacterial infections 
(Goodridge and Abedon 2003).105
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Enhancement of Phage Fitness
In this section we reﬂ  ect on the VF impact on 
phage propagation. We consider a positive impact 
to be something that results in an increased phage 
burst size, a decreased phage latent period (that 
is, a reduced phage generation time but without 
burst-size/fecundity cost; Abedon et al 2003), or 
an increased Darwinian ﬁ  tness associated with 
phage progeny. This idea of a phage utility to 
phage-encoded VFs is not novel, though has not 
been rigorously explored. Levin (1996), for 
example, rhetorically asks how toxins might 
“confer an advantage” on bacteria “or the plas-
mids and phages that code for these toxins” 
(emphasis added). Wagner and Waldor (2002) 
suggest that phage or VF genes could serve as 
units of selection while Davis and Waldor (2002) 
remind us that “It is possible that prophage induc-
tion generally facilitates survival of the phage 
genome more than that of the bacterial host spe-
cies.” Furthermore, Novick (2003) notes that 
“Mobile genetic elements are arguably selﬁ  sh in 
that their evolution is driven by selective forces 
that operate on the elements themselves, indepen-
dently of the host organisms within which they 
must of necessity reside.” Here we expand on 
these speculations.
9. Direct enhancement of phage 
ﬁ  tness (eg, as by dual utility)
Perhaps VF expression can directly contribute to 
a greater burst size by the expressing phage (Bishai 
and Murphy 1988) or, alternatively, perhaps VF 
association with virion particles could be of dual 
utility to virion and bacterial pathogen (Bensing 
et al 2001; Wagner and Waldor 2002; Gentry-
Weeks et al 2002; Boyd and Brüssow 2002; Davis 
and Waldor 2002; Brüssow et al 2004; Boyd 2005). 
Also consistent with a dual utility (though just 
barely) would be the retention of genes, including 
VF genes or even random pieces of DNA, that 
could contribute to phage ﬁ  tness as a consequence 
of size-dependent efﬁ  ciencies of phage-genome 
packaging in phage capsids (Hendrix et al 2000). 
Below we suggest an alternative to these various 
“dual-utility” hypotheses, suggesting instead that 
prophage-encoded VFs could enhance phage 
propagation through a more indirect route than a 
direct enhancement of infection ﬁ  tness: modiﬁ  ca-
tion of the extra bacterial ecosystems within which 
phage propagate.
10. Indirect enhancement of phage 
ﬁ  tness (by ecosystem modiﬁ  cation)
What is accomplished with VF expression? In 
general terms, it is ecosystem modiﬁ  cation, par-
ticularly given VFs for which an effective dose 
may be disseminated throughout a bacterial com-
munity. Typically this dissemination would be of 
soluble factors such as exotoxins, and historically 
exotoxins have been the VFs most closely 
associated with phage (Wagner and Waldor 2002; 
Wagner and Waldor 2006). Disease is an obvious 
consequence of ecosystem modification (eg, 
despoilment of the human-or animal-body environ-
ment), and it is of interest that exotoxins capable 
of inducing toxinoses, diseases that can be caused 
solely by the presence of a single toxin, are almost 
all carried by “highly mobile genetic elements” 
(Novick 2003).
Ecosystem modiﬁ  cation, unless representing 
some unintended consequence of VF expression, 
should provide some benefit to the expresser, 
whether this is to the encoding gene, the carrying 
phage, or the expressing lysogen. For the phage, 
ﬁ  tness beneﬁ  ts may be measured in terms of bac-
teria successfully infected within a given ecosys-
tem (ie, within-culture phage population growth) 
or in terms of successful phage dissemination to 
new eco-systems (between-culture phage transmis-
sion). Phage ﬁ  tness therefore may be enhanced if 
exotox-ins are capable of (i) increasing the health 
or metabolic activity of phage-susceptible bacteria 
(resulting, given phage infection, in increased 
phage burst sizes or decreased phage latent periods; 
Hadas et al 1997), (ii) by increasing the number or 
density of phage-susceptible bacteria available to 
free phage, (iii) by increasing free-phage diffusion 
rates within environments, or (iv) by increasing 
environmental mixing and therefore the likelihood 
that free phage will be transmitted to new locations 
that are inhabited by phage-susceptible bacteria.
Each of these criteria could be met by exotoxin 
production resulting in ecosystem modiﬁ  cation. 
Exotoxin production, for instance, could lead to 
an increased availability within environments of 
nutrients—such as by Shiga toxin-mediated release 
of blood into the intestinal lumen (O’Loughlin and 
Robins-Browne 2001) or diphtheria toxin-medi-
ated release of nutrients from killed human cells 
(Ewald 2004). These nutrient increases could 
result in a boost (i) in the health of or (ii) in the 
number or density of phage-susceptible bacteria. 106
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Exotoxin production could also result, for example, 
in a loosening of stools. This stool loosening could 
result (iii) in decreases in environment viscosity 
or (iv) in increases in environmental mixing, in 
either case resulting in increased rates or likelihood 
of virion dissemination. Thus, a phage that 
expressed an exotoxin could set up subsequently 
produced free-phage progeny for faster or broader 
environmental dissemination than a similar phage 
that did not produce the exotoxin. As follows we 
discuss in greater detail this potential for exotoxin 
production to enhance phage ﬁ  tness.
10a. Indirect enhancement of phage 
replication by ecosystem modiﬁ  cation
For phage-encoded exotoxins that may be 
expressed independent of free-phage production, 
toxin production could be a means by which pro-
phage prepare their environment for subsequent 
phage growth. This growth could be by means of 
lysogen division, implying equivalence between 
toxin production and provision of a peace offer 
(Brüssow et al 2004). Alternatively, an induced 
lysogen may produce more phage progeny (ie, 
display a greater burst size) if previous toxin pro-
duction results in greater lysogen physiological 
health. In addition, and consistent with a central 
tenet particularly of Smith’s (2001) take on effec-
tive toxin-dose dissemination, bacteria not produc-
ing exotoxins also might beneﬁ  t from exotoxin 
production. If these bacteria are phage susceptible, 
then—by increasing the density or health of these 
other bacteria—the fitness of phage progeny 
released from induced lysogens should also be 
enhanced. Thus, one can view exotoxins as impact-
ing favorably on phage growth in situ whether 
phage are growing as stable lysogens, as induced 
lysogens, or as released virions.
This phage plus lysogen advantage collapses to 
just a lysogen (or bacterium) advantage if prophage 
are defective, which in turn collapses to assump-
tions only of inclusive ﬁ  tness if the host bacterium 
also must be killed to effect exotoxin expression. 
In the first instance the prophage cannot take 
advantage of improvement in conditions for virion-
mediated population growth because the prophage 
cannot produce functional virions. In the second 
instance, even the expressing bacterium cannot 
take advantage of improvements in conditions 
because the bacterium dies long before conditions 
improve. Note, then, the narrow distinction 
between inclusive ﬁ  tness gains and phage gains: 
Inclusive-ﬁ  tness gains are a function solely of the 
ﬁ  tness gains made by intact bacteria that also har-
bor the toxin gene whereas non-defective prophage, 
by releasing free-phage progeny, additionally may 
beneﬁ  t from gains made by phage-susceptible 
bacteria—bacteria that do not necessarily harbor 
the toxin gene. Thus, there is a similarity between 
these seemingly distinct gains, bacterium versus 
phage: Both, as posited, have to do with ecosystem 
modiﬁ  cation such that bacteria, at least over the 
short term, display an enhanced potential for 
growth.
This view of phage modifying their environ-
ment in a manner that enhances bacterial growth 
is not necessarily limited to the impact of phage-
encoded VFs. Indeed, phage-induced bacterial lysis 
alone should result in the release of previously 
sequestered nutrients, ie, those formerly associated 
with not-lysed bacteria, which could then become 
available to surviving bacteria [see (Weinbauer 
2004; Abedon 2006; Miller 2006) for reviews of 
this concept as applied to aquatic environments]. 
Furthermore, lysed bacteria can release ectoen-
zymes (Morita 1997), which are normally intracel-
lular hydrolytic enzymes that can break down 
extracellular substrates that otherwise may be 
unavailable as a nutrient source to neighboring 
bacteria. Thus, we can describe at least three routes 
toward bacteria nutrient acquisition that could 
become available as a consequence of phage 
action: lysing of neighboring bacteria, ectoenzyme 
action on otherwise unavailable substrates, and the 
degradation (or invasion) of eukaryote-host tissues 
via the action of phage-encoded VFs. All three 
mechanisms could beneﬁ  t phage virions, lysogens, 
or bacterial infections, as well as neighboring 
bacteria that are not phage infected. The resulting 
beneﬁ  ts are equivalent in their location dependence 
to beneﬁ  ts accrued more generally by proximity 
to such soluble bacterial factors as exoen-zymes 
or bacteria-encoded exotoxins.
10b. Indirect enhancement of virion 
dissemination by ecosystem 
modiﬁ  cation
Increasing physical movement, like increasing 
nutrient densities, could also benefit phages, 
resulting in selection for continued association 
between phage and movement-enhancing VF 
genes. Such movement could occur within as well 107
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as between bacteria-containing environments. 
Within bacteria-containing environments various 
phage-mediated modiﬁ  cations of virion movement 
are already known, particularly ones that facilitate 
phage movement to the surface of phage-susceptible 
bacteria. Enzymatic degradation of materials asso-
ciated with the bacterium that a phage is adsorb-
ing—with enzymes displayed, for example, by 
virion particles— are probably fairly common (eg, 
bacterial hyaluroni-dase; Baker et al 2002; Brüssow 
2006) (also Hughes et al 1998; Scholl et al 2001). 
Alternatively, Broudy et al (2002) suggest that 
soluble phage-encoded enzymes could enhance 
phage diffusion away from lysed bacteria. They 
argue, in particular, that phage spd1 of Streptococ-
cus pyogenes encodes a DNase that could aid in 
the breakdown of the bacterium chromosome fol-
lowing phage-induced bacterial lysis, reducing 
local viscosity and thereby aiding phage diffusion 
to new phage-susceptible bacteria. As a VF this 
DNase could also aid, as these authors note, in the 
liquefaction of pus [see Prevelige (2006) for a 
similar “diffusion-away” function attributed to the 
tailspike protein of Salmonella phage P22].
Phage-encoded VFs can also facilitate phage 
movement between bacteria-containing environ-
ments. The basic idea that physical movement 
between environments could select for VFs is sum-
marized by Ewald (1994). That is, selection for 
increased pathogen virulence can result if the 
physical transfer of pathogens to new hosts is 
augmented by mechanisms that reduce former-host 
health. Diarrhea, for instance, is not necessarily an 
incidental consequence of pathogen infection but 
instead may serve as an efﬁ  cient means by which 
enteric pathogens move their kind out of colons 
(Ewald 1994; Wagner and Waldor 2002; Davis and 
Waldor 2002; Brüssow et al 2004). Free-phage 
transmission between hosts (eg, from one colon to 
another) presumably could be augmented by the 
same mechanism. Thus, to the degree that diarrhea 
is a consequence of the expression of phage genes 
(eg, Livny and Friedman 2004), then one can envis-
age diarrhea as phage-mediated bacterial virulence 
that is selected precisely because it increases phage 
transmission to new ecosystems.
Diarrhea-like loosening of stools might also 
foster more-rapid mixing and phage diffusion 
within environments, thereby resulting in greater 
availability to phage of phage-susceptible bacteria 
within colons. Diarrhea, therefore, may be 
described as potentially aiding free-phage 
transmission to new bacteria within colonic envi-
ronments as well as aiding free-phage or lysogen 
transmission between colons. In addition, it is 
conceivable that a localized stool loosening, such 
as to a degree that does not necessarily give rise to 
noticeable symptoms of diarrhea, could also locally 
aid phage dissemination within colons to suscep-
tible bacteria. Thus, even given an absence of 
sufﬁ  cient stool loosening so that phage (and bac-
teria) dissemination out of animals is enhanced, 
phage-encoded enterotoxins might still augment 
the ﬁ  tness of encoding phage by means of local 
enhancement of virion dissemination.
Infection Type and Exotoxin Utility
Perhaps the most striking conclusion from our 
analysis of mechanisms potentially retaining phage-
VF gene associations is the relative dearth of 
mechanisms enhancing the ﬁ  tness of individual 
bacteria. The sole mechanism we have identiﬁ  ed 
is epistatic interactions between phage and VF 
genes (mechanism 6), but only given that linkage 
between those genes is a reasonable response to 
such epista-sis and even then only if VF expression 
doesn’t coincide with death of the bacterial lyso-
gens (eg, such death is necessary for Shiga toxin 
release). Instead, the bottom line for phage-VF gene 
association is that for such an association to be 
stably maintained there must be an advantage for 
the gene to remain in association with a functional 
phage genome. For a phage genome to be func-
tional, from an ecological vantage, then phage-
susceptible bacteria must be obtainable by released 
phage progeny such that the phage life cycle may 
be completed. We would argue that this functional 
requirement for bacteria to infect, and not just for 
phage production, could signiﬁ  cantly constrain the 
evolutionary maintenance of associations between 
functional phage genomes and VF genes. That is, 
bacterial infections that are too invasive may be too 
homogeneous in terms of bacterial types present to 
provide temperate phages with susceptible bacterial 
prey, ie, ones not already lysogenized by the same 
phage. Too-invasive bacterial infections also may 
be too sealed off from the outside world to provide 
phages with a reasonable potential to disseminate 
to susceptible bacteria found elsewhere, other than 
via the normal bacterial portal of exit.
For these more sealed off infections we would 
envisage a closer correspondence between phage 108
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and bacterial interests, including mechanisms of 
dissemination. That is, there could be less reason 
for eukaryote-tissue modifying genes to be phage 
rather than bacterium encoded. Mucous mem-
branes, by contrast, more likely carry normal-ﬂ  ora 
bacteria than do tissues that are deeply buried 
within animal bodies. It is of interest in terms of 
VF utility, therefore, that the three best studied of 
phage-encoded exotoxins—diphtheria toxin as 
produced by Corynebacterium diphtheriae, Shiga 
toxin as produced by Shiga toxigenic E. coli such 
as E. coli O157, and Cholera toxin as produced by 
Vibrio cholerae—are all associated with infections 
in which bacteria do not actively invade host tis-
sues but instead are limited to colonization on 
mucous membranes (eg, Bloom and Boedeker 
1996; O’Loughlin and Robins-Browne 2001; 
Foxwell et al 2004).
We suggest that the phage utility of VFs in 
general and the phage utility of exotoxins in par-
ticular may be found under those circumstances 
where modiﬁ  cation of the eukaryote-host environ-
ment allows increased phage potential for acquisi-
tion of new bacterial prey. In these circumstances 
phage biology and ecology—eg, as by disseminat-
ing an effective toxin dose—may impact dramati-
cally on resulting disease. To better understand not 
only the evolution of bacterial pathogens, but also 
the progression of bacterial disease, it therefore 
may be necessary to understand phage-encoded 
VFs not just from the perspective of expressing 
bacteria, but also in terms of the ecology of entire 
ecosystems. Of great pertinence, therefore, is 
determining which factors control phage impact 
in situ such as rates of lysogen induction, relative 
likelihoods of lytic versus lysogenic infection, 
phage burst size, phage host range, evolutionary 
dynamics of phage-associated genes, and the abil-
ity of purely lytic infections to produce bacterial 
toxins. Ultimately this knowledge of phage biology 
may promote not just a better understanding of 
those forces impacting phage-VF associations, but 
also a better understanding of prophage-mediated 
disease processes themselves.
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